Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech center experience

被引：5
|
作者：
Weinbergerova, Barbora [1 ,2 ]
Cernan, Martin [3 ,4 ]
Kabut, Tomas [1 ,2 ]
Semerad, Lukas [1 ,2 ]
Podstavkova, Natalia [1 ,2 ]
Szotkowski, Tomas [3 ,4 ]
Jeziskova, Ivana
Mayer, Jiri [1 ,2 ]
机构：
[1] Masaryk Univ, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Palacky Univ Olomouc, Fac Med & Dent, Dept Hemato Oncol, Olomouc, Czech Republic
[4] Univ Hosp Olomouc, Olomouc, Czech Republic
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 10期
关键词：
CHEMOTHERAPY;
D O I：
10.3324/haematol.2022.282263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2826 / 2829
页数：4
相关论文
共 50 条
  • [21] Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia
    Chen, Nianci
    Pan, Jiajia
    Zhou, Yile
    Mao, Liping
    Lou, Yinjun
    Qian, Jiejing
    Xu, Gaixiang
    Wei, Juying
    Zhou, De
    Shou, Lihong
    Huang, Li
    Yan, Minchao
    Zeng, Hui
    Fan, Cuihua
    Wu, Gongqiang
    Feng, Weiying
    Tong, Hongyan
    Jin, Jie
    Wang, Huafeng
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 861 - 870
  • [22] Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study
    Laurino, Marica
    Loron, Sandrine
    Larcher, Marie-Virginie
    Fossard, Gaelle
    Elhamri, Mohamed
    Deloire, Alexandre
    Balsat, Marie
    Barraco, Fiorenza
    Labussiere, Helene
    Ducastelle, Sophie
    Renault, Myriam
    Wattel, Eric
    Heiblig, Mael
    Salles, Gilles
    Thomas, Xavier
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [23] High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia
    Oya, Shuki
    Ozawa, Hidetoshi
    Morishige, Satoshi
    Maehiro, Yoshimi
    Umeda, Masahiro
    Takaki, Yusuke
    Fukuyama, Toshinobu
    Yamasaki, Yoshitaka
    Nakamura, Takayuki
    Yamaguchi, Maki
    Aoyama, Kazutoshi
    Mouri, Fumihiko
    Nagafuji, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (03) : 297 - 304
  • [24] 19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
    Lara, Joshua J.
    Bencomo-Alvarez, Alfonso E.
    Gonzalez, Mayra A.
    Olivas, Idaly M.
    Young, James E.
    Lopez, Jose L.
    Velazquez, Vanessa V.
    Glovier, Steven
    Keivan, Mehrshad
    Rubio, Andres J.
    Dang, Sara K. K.
    Solecki, Jonathan P.
    Allen, Jesse C.
    Tapia, Desiree N.
    Tychhon, Boranai
    Astudillo, Gonzalo E.
    Jordan, Connor
    Chandrashekar, Darshan S.
    Eiring, Anna M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [25] Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study
    Griffin, James D.
    Yang, Hongbo
    Song, Yan
    Kinrich, David
    Shah, Manasee V.
    Bui, Cat N.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 341 - 350
  • [26] Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
    Voso, Maria Teresa
    Larson, Richard A.
    Jones, Dan
    Marcucci, Guido
    Prior, Thomas
    Krauter, Jurgen
    Heuser, Michael
    Lavorgna, Serena
    Nomdedeu, Josep
    Geyer, Susan M.
    Walker, Alison
    Wei, Andrew H.
    Sierra, Jorge
    Sanz, Miguel A.
    Brandwein, Joseph M.
    de Witte, Theo M.
    Jansen, Joop H.
    Niederwieser, Dietger
    Appelbaum, Frederick R.
    Medeiros, Bruno C.
    Tallman, Martin S.
    Schlenk, Richard F.
    Ganser, Arnold
    Amadori, Sergio
    Cheng, Yuan
    Chen, YinMiao
    Pallaud, Celine
    Du, Ling
    Piciocchi, Alfonso
    Ehninger, Gerhard
    Byrd, John
    Thiede, Christian
    Dohner, Konstanze
    Stone, Richard M.
    Dohner, Hartmut
    Bloomfield, Clara D.
    Lo-Coco, Francesco
    BLOOD ADVANCES, 2020, 4 (19) : 4945 - 4954
  • [27] Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia
    Wang, Eunice S.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 105 - 112
  • [28] Midostaurin for the treatment of adult patients with newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive
    Garcia, J. S.
    Percival, M. E.
    DRUGS OF TODAY, 2017, 53 (10) : 531 - 543
  • [29] Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia A case report
    Bae, Nan Young
    Byun, Ja Min
    Kang, Chang Kyung
    Choe, Pyoeng Gyun
    Kim, Nam Joong
    Kim, Min-Sung
    Park, Kyu Joo
    Yoon, Sung-Soo
    MEDICINE, 2022, 101 (04) : E28700
  • [30] Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia
    Wu, Shuangshuang
    Edwards, Holly
    Wang, Deying
    Liu, Shuang
    Qiao, Xinan
    Carter, Jenna
    Wang, Yue
    Taub, Jeffrey W.
    Wang, Guan
    Ge, Yubin
    CELLS, 2022, 11 (17)
12345